Application of electroporation in DNA vaccination protocols

Pieranna Chiarella, Vito M. Fazio, Emanuela Signori

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Vaccination is historically one of the most important methods for preventing infectious diseases in humans and animals. Due to recent advances in understanding the biology of the immune system, a more rational design of vaccines and vaccination strategies such as those based on gene transfer has been proposed. In particular, naked DNA vaccination is emerging as a promising approach for introducing foreign antigens into the host, inducing protective immunity against infectious diseases and malignant tumours. Plasmid DNA vaccines offer several advantages in comparison to traditional vaccines such as safety, tolerability and feasibility in manufacture. Nevertheless, because of their poor immunogenicity, plasmid DNA vaccines need further implementation. Recent data suggest electroporation as a useful strategy to improve DNA-based vaccination protocols, being able to stimulate both the humoural and cellular immune responses. In preclinical trials, electroporation is successfully used in prime-boost combination protocols and its efficacy and tolerability have been demonstrated in Phase I clinical trials. Since these initial results appear promising, in the next future we will assist further developments of naked DNA vaccination associated to the electroporation technology. This approach not only provides the basis for human studies but also a practical application to veterinary medicine.

Original languageEnglish
Pages (from-to)281-286
Number of pages6
JournalCurrent Gene Therapy
Volume10
Issue number4
DOIs
Publication statusPublished - 2010

Fingerprint

Electroporation
Vaccination
DNA
DNA Vaccines
Communicable Diseases
Plasmids
Vaccines
Clinical Trials, Phase I
Veterinary Medicine
Cellular Immunity
Immune System
Immunity
Technology
Safety
Antigens
Genes
Neoplasms

Keywords

  • Cancer vaccines
  • DNA vaccines
  • Electroporation
  • Gene therapy

ASJC Scopus subject areas

  • Genetics
  • Molecular Biology
  • Molecular Medicine
  • Genetics(clinical)
  • Drug Discovery

Cite this

Application of electroporation in DNA vaccination protocols. / Chiarella, Pieranna; Fazio, Vito M.; Signori, Emanuela.

In: Current Gene Therapy, Vol. 10, No. 4, 2010, p. 281-286.

Research output: Contribution to journalArticle

Chiarella, Pieranna ; Fazio, Vito M. ; Signori, Emanuela. / Application of electroporation in DNA vaccination protocols. In: Current Gene Therapy. 2010 ; Vol. 10, No. 4. pp. 281-286.
@article{7eb4293263264feca866c3235db09f37,
title = "Application of electroporation in DNA vaccination protocols",
abstract = "Vaccination is historically one of the most important methods for preventing infectious diseases in humans and animals. Due to recent advances in understanding the biology of the immune system, a more rational design of vaccines and vaccination strategies such as those based on gene transfer has been proposed. In particular, naked DNA vaccination is emerging as a promising approach for introducing foreign antigens into the host, inducing protective immunity against infectious diseases and malignant tumours. Plasmid DNA vaccines offer several advantages in comparison to traditional vaccines such as safety, tolerability and feasibility in manufacture. Nevertheless, because of their poor immunogenicity, plasmid DNA vaccines need further implementation. Recent data suggest electroporation as a useful strategy to improve DNA-based vaccination protocols, being able to stimulate both the humoural and cellular immune responses. In preclinical trials, electroporation is successfully used in prime-boost combination protocols and its efficacy and tolerability have been demonstrated in Phase I clinical trials. Since these initial results appear promising, in the next future we will assist further developments of naked DNA vaccination associated to the electroporation technology. This approach not only provides the basis for human studies but also a practical application to veterinary medicine.",
keywords = "Cancer vaccines, DNA vaccines, Electroporation, Gene therapy",
author = "Pieranna Chiarella and Fazio, {Vito M.} and Emanuela Signori",
year = "2010",
doi = "10.2174/156652310791823506",
language = "English",
volume = "10",
pages = "281--286",
journal = "Current Gene Therapy",
issn = "1566-5232",
publisher = "Bentham Science Publishers B.V.",
number = "4",

}

TY - JOUR

T1 - Application of electroporation in DNA vaccination protocols

AU - Chiarella, Pieranna

AU - Fazio, Vito M.

AU - Signori, Emanuela

PY - 2010

Y1 - 2010

N2 - Vaccination is historically one of the most important methods for preventing infectious diseases in humans and animals. Due to recent advances in understanding the biology of the immune system, a more rational design of vaccines and vaccination strategies such as those based on gene transfer has been proposed. In particular, naked DNA vaccination is emerging as a promising approach for introducing foreign antigens into the host, inducing protective immunity against infectious diseases and malignant tumours. Plasmid DNA vaccines offer several advantages in comparison to traditional vaccines such as safety, tolerability and feasibility in manufacture. Nevertheless, because of their poor immunogenicity, plasmid DNA vaccines need further implementation. Recent data suggest electroporation as a useful strategy to improve DNA-based vaccination protocols, being able to stimulate both the humoural and cellular immune responses. In preclinical trials, electroporation is successfully used in prime-boost combination protocols and its efficacy and tolerability have been demonstrated in Phase I clinical trials. Since these initial results appear promising, in the next future we will assist further developments of naked DNA vaccination associated to the electroporation technology. This approach not only provides the basis for human studies but also a practical application to veterinary medicine.

AB - Vaccination is historically one of the most important methods for preventing infectious diseases in humans and animals. Due to recent advances in understanding the biology of the immune system, a more rational design of vaccines and vaccination strategies such as those based on gene transfer has been proposed. In particular, naked DNA vaccination is emerging as a promising approach for introducing foreign antigens into the host, inducing protective immunity against infectious diseases and malignant tumours. Plasmid DNA vaccines offer several advantages in comparison to traditional vaccines such as safety, tolerability and feasibility in manufacture. Nevertheless, because of their poor immunogenicity, plasmid DNA vaccines need further implementation. Recent data suggest electroporation as a useful strategy to improve DNA-based vaccination protocols, being able to stimulate both the humoural and cellular immune responses. In preclinical trials, electroporation is successfully used in prime-boost combination protocols and its efficacy and tolerability have been demonstrated in Phase I clinical trials. Since these initial results appear promising, in the next future we will assist further developments of naked DNA vaccination associated to the electroporation technology. This approach not only provides the basis for human studies but also a practical application to veterinary medicine.

KW - Cancer vaccines

KW - DNA vaccines

KW - Electroporation

KW - Gene therapy

UR - http://www.scopus.com/inward/record.url?scp=77958026029&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77958026029&partnerID=8YFLogxK

U2 - 10.2174/156652310791823506

DO - 10.2174/156652310791823506

M3 - Article

C2 - 20504275

AN - SCOPUS:77958026029

VL - 10

SP - 281

EP - 286

JO - Current Gene Therapy

JF - Current Gene Therapy

SN - 1566-5232

IS - 4

ER -